Insulet Corporation (PODD)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $10.08B
Last updated: Nov 17, 2026 at 4:39 PM ET
Insulet Corporation (PODD) Statistics
Insulet (PODD) has a market cap of $10.08B and an enterprise value of $10.46B. Its trailing P/E of 22.0x is below its 5-year median of 79.1x. Revenue grew 26.46% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 3.75% above the market cap, as debt exceeds cash.
| Market Cap | $10.08B |
|---|---|
| Enterprise Value | $10.46B |
| Latest price (Nov 17, 2026) | $145.34 |
Key Dates
The next earnings report is expected on Feb 16, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 16, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.2x and 6.4x. Its year-end P/E ranged from 57.1x to 798.8x from 2019 to 2025.
| P/E Ratio | 22.0x |
|---|---|
| Forward P/E | 21.2x |
| P/S Ratio | 3.2x |
| Forward P/S | 3.1x |
| P/B Ratio | 6.4x |
| P/TBV Ratio | 7.1x |
| P/FCF Ratio | 41.8x |
| P/OCF Ratio | 19.8x |
| PEG Ratio | 0.9 |
Enterprise Valuation
Counting debt and cash, the company is valued at 15.0x EBITDA and 43.4x free cash flow.
| EV / Earnings | 24.4x |
|---|---|
| EV / Sales | 3.3x |
| EV / EBITDA | 15.0x |
| EV / EBIT | 17.7x |
| EV / FCF | 43.4x |
Price Statistics
The stock is down 56.31% over 52 weeks and trades 2.24% above its 50-day average.
| Beta (1Y) | 0.50 |
|---|---|
| 52-Week Change | -56.31% |
| 1-Month Change | +2.38% |
| 3-Month Change | -4.07% |
| 6-Month Change | -6.00% |
| 5-Year Change | -51.72% |
| 10-Year Change | +303.23% |
| Total Return (1Y) | -56.31% |
| Total Return (3Y CAGR) | -5.83% |
| Total Return (5Y CAGR) | -13.66% |
| Return vs SPY (1Y) | -67.97% |
| Max Drawdown (1Y) | -62.33% |
| Max Drawdown (3Y) | -63.02% |
| Sharpe Ratio (1Y) | -1.75 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $142.16 |
| 200-Day Average | $171.60 |
| 52-Week Range | $126.40 to $354.88 |
| RSI (14 Days) | 47.4 |
| Average Volume (20 Days) | 1.35M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.51x current liabilities, and total debt is 0.61x shareholder equity.
| Current Ratio | 2.51x |
|---|---|
| Quick Ratio | 1.83x |
| Debt / Equity | 0.61x |
| Debt / EBITDA | 1.38x |
| Debt / FCF | 3.99x |
| Interest Coverage | 9.89x |
Returns and Efficiency
Return on invested capital is 18.14% over the last 12 months, against a 5-year average of 8.58%.
| Return on Equity (ROE) | 27.15% |
|---|---|
| Return on Assets (ROA) | 12.56% |
| Return on Invested Capital (ROIC) | 18.14% |
| Return on Capital Employed (ROCE) | 22.70% |
| ROE (5Y Average) | 16.59% |
| ROA (5Y Average) | 6.06% |
| ROIC (5Y Average) | 8.58% |
| Asset Turnover | 0.99x |
| Inventory Turnover | 1.73x |
| Receivables Turnover | 4.99x |
| Cash Conversion Cycle | 226 days |
Taxes
Income tax took 21.91% of pretax income over the last 12 months.
| Income Tax (TTM) | $120.30M |
|---|---|
| Effective Tax Rate | 21.91% |
Scores
PODD has an Altman Z-Score of 5.48, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.48 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $3.19B over the last 12 months.
| Revenue | $3.19B |
|---|---|
| Revenue Growth (YoY) | +26.46% |
| Gross Profit | $2.29B |
| Operating Income | $587.80M |
| Pretax Income | $549.10M |
| Net Income | $428.80M |
| EBITDA | $698.80M |
| EBIT | $590.40M |
| Reported EPS (TTM) | $6.62 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 46.20% of the $3.42B in total assets.
| Cash and Equivalents | $584.40M |
|---|---|
| Total Debt | $962.10M |
| Net Debt | $377.70M |
| Net Debt Per Share | $5.45 |
| Working Capital | $1.23B |
| Shareholder Equity | $1.58B |
| Book Value Per Share | $22.77 |
| Tangible Book Value | $1.41B |
| Tangible Book Per Share | $20.37 |
| Total Assets | $3.42B |
| Total Liabilities | $1.84B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $267.80M of capital spending, operating cash flow left $241.20M of free cash flow.
| Operating Cash Flow | $509.00M |
|---|---|
| Capital Expenditures | $267.80M |
| Free Cash Flow | $241.20M |
| FCF Per Share | $3.48 |
| Depreciation and Amortization | $108.40M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 18.43%, against a 5-year average of 11.94%.
| Gross Margin | 71.88% |
|---|---|
| Operating Margin | 18.43% |
| Pretax Margin | 17.22% |
| Net Margin | 13.45% |
| EBITDA Margin | 21.91% |
| EBIT Margin | 18.51% |
| FCF Margin | 7.56% |
| Gross Margin (5Y Average) | 67.99% |
| Operating Margin (5Y Average) | 11.94% |
| Net Margin (5Y Average) | 8.67% |
Growth
Revenue grew 27.54% a year over 3 years, and EPS 72.51% a year.
| Revenue Growth (3Y CAGR) | +27.54% |
|---|---|
| Revenue Growth (5Y CAGR) | +24.53% |
| EPS Growth (3Y CAGR) | +72.51% |
| EPS Growth (5Y CAGR) | +73.15% |
| Operating Income Growth (3Y CAGR) | +132.70% |
| Book Value Per Share Growth (2Y CAGR) | +42.99% |
| Tangible Book Per Share Growth (2Y CAGR) | +51.20% |
Dividends and Yields
PODD does not pay a dividend. Its free cash flow yield is 2.39%.
| Earnings Yield | 4.55% |
|---|---|
| FCF Yield | 2.39% |
| Buyback Yield | 2.90% |
| Shareholder Yield | 2.90% |
Peer Position
Against 9 similar companies, PODD has the 7th highest P/E.
P/E RatioPeer median 23.6x
P/S RatioPeer median 3.5x
ROICPeer median 5.14%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +5.55%
| P/E Ratio | 22.0x vs 23.6x median |
|---|---|
| P/S Ratio | 3.2x vs 3.5x median |
| ROIC | 18.14% vs 5.14% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +26.46% vs +5.55% median |
Analyst Forecast
Consensus estimates put revenue growth at 16.75% and EPS growth at 26.03% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +16.75% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +26.03% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PODD
What is PODD's market cap?
Insulet has a market cap of $10.08B. Its enterprise value, which adds debt and subtracts cash, is $10.46B.
What is PODD's P/E ratio?
Insulet has a trailing P/E ratio of 22.0x and a forward P/E of 21.2x.
How many shares of PODD are outstanding?
Insulet has 69.36M shares outstanding. The count is down 1.43% from a year earlier.
Does PODD pay a dividend?
No. Insulet does not pay a dividend.
How much debt does PODD have?
Insulet has $962.10M of total debt and $584.40M of cash and equivalents, a net debt position of $377.70M.
PODD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors